<ArticleSet>
<Article>
<Journal>
<PublisherName></PublisherName>
<JournalTitle>International Journal of Preventive Medicine</JournalTitle>
<Issn>2008-7802</Issn>
<Volume>2</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2011</Year>
<Month>04</Month>
<Day>21</Day>
</PubDate>
</Journal>
<ArticleTitle>Does Lipoprotein (a) Level Have a Predictive Value in Restenosis after Co-ronary Stenting?</ArticleTitle>
<FirstPage>166</FirstPage>
<LastPage>166</LastPage>
<Language>EN</Language>
<AuthorList>
<Author>
<FirstName>Alireza</FirstName>
<LastName>Khosravi</LastName>
</Author>
<Author>
<FirstName>Masoud</FirstName>
<LastName>Pourmoghaddas</LastName>
</Author>
<Author>
<FirstName>Fereshteh</FirstName>
<LastName>Ziaie</LastName>
</Author>
<Author>
<FirstName>Arezoo</FirstName>
<LastName>Enteshari</LastName>
</Author>
<Author>
<FirstName>Arsalan</FirstName>
<LastName>Khaledifar</LastName>
</Author>
<Author>
<FirstName>Ahmad</FirstName>
<LastName>Bahonar</LastName>
<Affiliation>MD, Physician, Isfahan Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.. ahmad.bahonar@gmail.com</Affiliation>
</Author>
</AuthorList>
<History>
<PubDate>
<Year>2011</Year>
<Month>04</Month>
<Day>19</Day>
</PubDate>
<PubDate>
<Year>2011</Year>
<Month>04</Month>
<Day>19</Day>
</PubDate>
</History>
<Abstract>Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and hypertension are the known risk factors for coronary artery diseases; however, their role is unknown in restenosis after coronary stenting. This study aimed to review the role of these factors, particularly lipoprotein (a) or Lp (a), as a predictive factor for restenosis after coronary stenting with Bare Metal Stent. Methods: In this study, coronary artery stenting was performed on 170 patients. Follow-up was done using coronary angiography in 128 patients, 6 months after conducting angioplasty. Clinical and biochemical characteristics of the patients were collected as prospective method and were compared between the patients with and without restenosis. Results: Restenosis was seen in 46 patients (35.9%). Fasting blood glucose level (FBG) in patients with restenosis was significantly higher than patients without restenosis (102.3 &plusmn; 39 mg/dl vs. 84.5 &plusmn; 28.9 [OR: 1.02, 95% CI: 1.00-1.04]). Lp (a) levels (OR: 0.54, 95% CI: 0.26-1.10) and other biochemical markers and clinical variables had no correlation with restenosis. Conclusions: Lipoproteins and lipids may not be the underlying cause of restenosis but accurate control of diabetes may improve prognosis after elective coronary stenting. Keywords: Stent, Restenosis, Lipoprotein (a), Lipid, Diabetes.</Abstract>
</Article>
</ArticleSet>